Adenine derivatives

US7977343B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Hans-Peter Buchstaller · Griesheim, DE
• Hans-Michael Eggenweiler · Darmstadt, DE
• Bertram Cezanne · Mörfelden, DE
• Michael Wolf · Darmstadt, DE

Key dates

• Filing date: Jul 20, 2006
• Grant date: Jul 12, 2011
• Expiry date: Feb 7, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel adenine derivatives of the formula (I), in which R1, R2, R3, X and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.